doping – SEMS-journal

Interdisciplinary care for users of anabolic agents in recreational sports in Switzerland – a first clinic has opened in Zurich

The use of anabolic androgenic steroids (AAS) as well as other image- and performance-enhancing drugs (IPEDs) has become one of the most recent global major substance use disorders in the 21st century. These substances are not only used by professional bodybuilders and competitive athletes, but moreover by recreational gym users aiming to achieve personal image and sports-performance goals [1].

antidoping sports and society doping supplements performance pharmacology

Ennuis judiciaires à cause de la DHEA

L’abréviation DHEA signifie déhydroépiandrostérone, un précurseur hormonal des hormones sexuelles masculines et féminines. La médecine dite «anti-âge» est à la mode et les cures d’hormones promettent une vie avec plus de plaisir et moins de troubles. De plus en plus de professionnelles de la santé recommandent la DHEA à leurs patients – souvent avec de lourdes conséquences!

antidoping

Doping and the Sports Physician’s Role – The Swiss Experience

Sports physicians who take care of both leisure and elite athletes tend to be confronted with doping practices in various facets. The authors of this article aimed to examine attitudes, knowledge and experiences regarding doping practices and anti-doping resources in a specially trained population of board-certified Swiss sport and exercise physicians using a questionnaire.

exercise is medicine

Die sportmedizinische Mannschaftsbetreuung – ein rechtliches Minenfeld?

From a legal point of view, sports medical team care is characterized by various areas of tension. In particular, sports physicians have to balance health protection with patient autonomy, professional secrecy with the protective rights of third parties, and enhancing physical performance with fair competition. These dilemmas occur in extremely compressed form in the case of head injuries during competition.

antidoping

Doping in sports – conscious lack of interest or ethical Everest?

Within a clinical sports medical setting the discussion about doping is insufficient. In elite-sports use of pharmaceutical agents is daily business in order to maintain the expected top-level performance. Unfortunately, a similar development could be observed in the general population of leisure athletes where medical supervision is absent. As a sports physician you are facing imminent ethical questions when standing in between. Therefore, we propose the application of a standardised risk score as a tool to promote doping-prevention and launch the debate within athlete-physician-relationship.

antidoping elite sports performance sports and society team management

Risk for a Swiss medical doctor involved in a doping affair

As soon as he prescibes medicine to an athlete, any physician is confrounted if he wants or not, and if he is aware of it or not, with the numerous and often complex rules treating with the universal fight against doping. In case of an involountary mistakee or not, the doctor can be involved in very unpleasant situations over different regulations. As ignorance is no valid defense form, it seems obvious that it is very imporant that each practitionner is informed the better possible about these legal aspects. This is the objective of the following presentation.

antidoping elite sports monitoring

Retesting the anti-doping samples: Best tool for deterrence?

Long term storage of the anti-doping samples and their reanalyses becomes today more and more a trend in the anti-doping community. The procedure has been implemented by the anti-doping authorities for the samples of the Tour de France and for the Olympic Games since Athens 2004 and has been always presented as a good tool to deter doping habits in top level sport. Recently, the World Anti-Doping Code introduced the possibility for anti-doping organizations to store the athletes’ samples up to ten years.

antidoping elite sports performance

Biological passport in athletes – role of the experts

The Athlete Biological Passport detects the effect of doping on the organism through longitudinal monitoring of biomarkers. The first quantitative analysis is performed by a software algorithm based on the Bayes theorem, taking into account previous values of the athlete. Profiles which have been found as abnormal with this technique are submitted for qualitative analysis to an expert panel regarding potential causes for the abnormality. Possible causes include analytical shortcomings, Pathologies, extremes of physiological regulation or doping.